Shedir Pharma Group Toekomstige groei
Future criteriumcontroles 3/6
Shedir Pharma Group is forecast to grow earnings and revenue by 7.9% and 6.3% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 12.7% in 3 years.
Belangrijke informatie
7.9%
Groei van de winst
7.8%
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 15.4% |
| Inkomstengroei | 6.3% |
| Toekomstig rendement op eigen vermogen | 12.7% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 15 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Shedir Pharma Group's (BIT:SHE) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 05
Why Shedir Pharma Group's (BIT:SHE) Earnings Are Better Than They Seem
Oct 05Is Shedir Pharma Group (BIT:SHE) Using Too Much Debt?
Apr 06What Type Of Returns Would Shedir Pharma Group's(BIT:SHE) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Dec 30
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 72 | 7 | 10 | 12 | 1 |
| 12/31/2025 | 68 | 7 | 8 | 11 | 1 |
| 12/31/2024 | 64 | 6 | 9 | 11 | 1 |
| 6/30/2024 | 61 | 6 | 6 | 9 | N/A |
| 3/31/2024 | 60 | 6 | 1 | 5 | N/A |
| 12/31/2023 | 59 | 6 | -4 | 1 | N/A |
| 9/30/2023 | 59 | 6 | -3 | 0 | N/A |
| 6/30/2023 | 58 | 6 | -2 | 0 | N/A |
| 3/31/2023 | 56 | 6 | 0 | 1 | N/A |
| 12/31/2022 | 53 | 6 | 1 | 3 | N/A |
| 9/30/2022 | 51 | 5 | 5 | 7 | N/A |
| 6/30/2022 | 49 | 4 | 10 | 11 | N/A |
| 3/31/2022 | 47 | 4 | 10 | 12 | N/A |
| 12/31/2021 | 45 | 4 | 10 | 12 | N/A |
| 9/30/2021 | 44 | 4 | 8 | 10 | N/A |
| 6/30/2021 | 43 | 3 | 7 | 9 | N/A |
| 3/31/2021 | 43 | 4 | 8 | 9 | N/A |
| 12/31/2020 | 43 | 4 | 9 | 10 | N/A |
| 9/30/2020 | 44 | 3 | 5 | 7 | N/A |
| 6/30/2020 | 45 | 3 | 1 | 3 | N/A |
| 3/31/2020 | 47 | 3 | -4 | -1 | N/A |
| 12/31/2019 | 51 | 3 | -5 | -3 | N/A |
| 9/30/2019 | 50 | 4 | -3 | -1 | N/A |
| 6/30/2019 | 49 | 5 | -1 | 0 | N/A |
| 3/31/2019 | 49 | 6 | 6 | 7 | N/A |
| 12/31/2018 | 47 | 7 | -3 | -1 | N/A |
| 12/31/2017 | 40 | 3 | N/A | 5 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: SHE's forecast earnings growth (7.9% per year) is above the savings rate (2.4%).
Winst versus markt: SHE's earnings (7.9% per year) are forecast to grow faster than the Italian market (7.3% per year).
Hoge groeiwinsten: SHE's earnings are forecast to grow, but not significantly.
Omzet versus markt: SHE's revenue (6.3% per year) is forecast to grow faster than the Italian market (3.9% per year).
Hoge groei-inkomsten: SHE's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: SHE's Return on Equity is forecast to be low in 3 years time (12.7%).